Modulation of cisplatin cytotoxicity by sulphasalazine

S. Awasthi, R. Sharma, S. S. Singhal, N. K. Herzog, M. Chaubey, Y. C. Awasthi

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The efficacy of cisplatin [cis-diamminedichloroplatinum (II); DDP] is hampered by acquired or de novo resistance of malignant cells to its cytotoxic effects. We have previously reported that cisplatin resistance parallels glutathione S-transferase (GST) activity in several human small-cell lung cancer cell lines. In the presently described studies, we used sulphasalazine, an inhibitor of GSTs, to evaluate the relative role of GSTs in mediating cisplatin resistance in two human small-cell lung cancer cell lines, NCI H-69 and H-2496. The H-69 cell line, which contained relatively higher GST activity than the H-2496 cell line (317 ± 7 vs 9 ± 1 mU mg-1 protein respectively), also displayed a greater degree of cisplatin resistance (IC50 values of 25.0 ± 3.9 vs 4.5 ± 1.0 microM respectively). Western blot and Northern blot analyses of purified GSTs revealed the expression of only the pi-class GST in both cell lines. Sulphasalazine inhibited the purified GSTs (IC50 of 10 microM for H-69 and 12 microM for H-2496) from both lines in a competitive manner with similar Ki values (6.5 and 7.9 microM for the H-69 and H-2496 cell lines respectively). Cytotoxicity studies revealed that sulphasalazine increased the cytotoxicity of cisplatin towards both cell lines. Isobologram analysis showed that sulphasalazine synergistically enhanced the cytotoxicity of cisplatin towards both cell lines, the magnitude of synergy being remarkably higher in H-69 cells than in H-2496 cells. Our studies indicate that clinically achievable concentrations of sulphasalazine may be useful in modulating cisplatin resistance in malignancies with increased GST-pi content.

Original languageEnglish (US)
Pages (from-to)190-194
Number of pages5
JournalBritish Journal of Cancer
Volume70
Issue number2
DOIs
StatePublished - 1994

Fingerprint

Sulfasalazine
Cisplatin
Cell Line
Glutathione S-Transferase pi
Small Cell Lung Carcinoma
Glutathione Transferase
Inhibitory Concentration 50
Northern Blotting
Western Blotting

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Awasthi, S., Sharma, R., Singhal, S. S., Herzog, N. K., Chaubey, M., & Awasthi, Y. C. (1994). Modulation of cisplatin cytotoxicity by sulphasalazine. British Journal of Cancer, 70(2), 190-194. https://doi.org/10.1038/bjc.1994.278

Modulation of cisplatin cytotoxicity by sulphasalazine. / Awasthi, S.; Sharma, R.; Singhal, S. S.; Herzog, N. K.; Chaubey, M.; Awasthi, Y. C.

In: British Journal of Cancer, Vol. 70, No. 2, 1994, p. 190-194.

Research output: Contribution to journalArticle

Awasthi, S, Sharma, R, Singhal, SS, Herzog, NK, Chaubey, M & Awasthi, YC 1994, 'Modulation of cisplatin cytotoxicity by sulphasalazine', British Journal of Cancer, vol. 70, no. 2, pp. 190-194. https://doi.org/10.1038/bjc.1994.278
Awasthi S, Sharma R, Singhal SS, Herzog NK, Chaubey M, Awasthi YC. Modulation of cisplatin cytotoxicity by sulphasalazine. British Journal of Cancer. 1994;70(2):190-194. https://doi.org/10.1038/bjc.1994.278
Awasthi, S. ; Sharma, R. ; Singhal, S. S. ; Herzog, N. K. ; Chaubey, M. ; Awasthi, Y. C. / Modulation of cisplatin cytotoxicity by sulphasalazine. In: British Journal of Cancer. 1994 ; Vol. 70, No. 2. pp. 190-194.
@article{90316910b0e246fda169ed847ebfa2b6,
title = "Modulation of cisplatin cytotoxicity by sulphasalazine",
abstract = "The efficacy of cisplatin [cis-diamminedichloroplatinum (II); DDP] is hampered by acquired or de novo resistance of malignant cells to its cytotoxic effects. We have previously reported that cisplatin resistance parallels glutathione S-transferase (GST) activity in several human small-cell lung cancer cell lines. In the presently described studies, we used sulphasalazine, an inhibitor of GSTs, to evaluate the relative role of GSTs in mediating cisplatin resistance in two human small-cell lung cancer cell lines, NCI H-69 and H-2496. The H-69 cell line, which contained relatively higher GST activity than the H-2496 cell line (317 ± 7 vs 9 ± 1 mU mg-1 protein respectively), also displayed a greater degree of cisplatin resistance (IC50 values of 25.0 ± 3.9 vs 4.5 ± 1.0 microM respectively). Western blot and Northern blot analyses of purified GSTs revealed the expression of only the pi-class GST in both cell lines. Sulphasalazine inhibited the purified GSTs (IC50 of 10 microM for H-69 and 12 microM for H-2496) from both lines in a competitive manner with similar Ki values (6.5 and 7.9 microM for the H-69 and H-2496 cell lines respectively). Cytotoxicity studies revealed that sulphasalazine increased the cytotoxicity of cisplatin towards both cell lines. Isobologram analysis showed that sulphasalazine synergistically enhanced the cytotoxicity of cisplatin towards both cell lines, the magnitude of synergy being remarkably higher in H-69 cells than in H-2496 cells. Our studies indicate that clinically achievable concentrations of sulphasalazine may be useful in modulating cisplatin resistance in malignancies with increased GST-pi content.",
author = "S. Awasthi and R. Sharma and Singhal, {S. S.} and Herzog, {N. K.} and M. Chaubey and Awasthi, {Y. C.}",
year = "1994",
doi = "10.1038/bjc.1994.278",
language = "English (US)",
volume = "70",
pages = "190--194",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Modulation of cisplatin cytotoxicity by sulphasalazine

AU - Awasthi, S.

AU - Sharma, R.

AU - Singhal, S. S.

AU - Herzog, N. K.

AU - Chaubey, M.

AU - Awasthi, Y. C.

PY - 1994

Y1 - 1994

N2 - The efficacy of cisplatin [cis-diamminedichloroplatinum (II); DDP] is hampered by acquired or de novo resistance of malignant cells to its cytotoxic effects. We have previously reported that cisplatin resistance parallels glutathione S-transferase (GST) activity in several human small-cell lung cancer cell lines. In the presently described studies, we used sulphasalazine, an inhibitor of GSTs, to evaluate the relative role of GSTs in mediating cisplatin resistance in two human small-cell lung cancer cell lines, NCI H-69 and H-2496. The H-69 cell line, which contained relatively higher GST activity than the H-2496 cell line (317 ± 7 vs 9 ± 1 mU mg-1 protein respectively), also displayed a greater degree of cisplatin resistance (IC50 values of 25.0 ± 3.9 vs 4.5 ± 1.0 microM respectively). Western blot and Northern blot analyses of purified GSTs revealed the expression of only the pi-class GST in both cell lines. Sulphasalazine inhibited the purified GSTs (IC50 of 10 microM for H-69 and 12 microM for H-2496) from both lines in a competitive manner with similar Ki values (6.5 and 7.9 microM for the H-69 and H-2496 cell lines respectively). Cytotoxicity studies revealed that sulphasalazine increased the cytotoxicity of cisplatin towards both cell lines. Isobologram analysis showed that sulphasalazine synergistically enhanced the cytotoxicity of cisplatin towards both cell lines, the magnitude of synergy being remarkably higher in H-69 cells than in H-2496 cells. Our studies indicate that clinically achievable concentrations of sulphasalazine may be useful in modulating cisplatin resistance in malignancies with increased GST-pi content.

AB - The efficacy of cisplatin [cis-diamminedichloroplatinum (II); DDP] is hampered by acquired or de novo resistance of malignant cells to its cytotoxic effects. We have previously reported that cisplatin resistance parallels glutathione S-transferase (GST) activity in several human small-cell lung cancer cell lines. In the presently described studies, we used sulphasalazine, an inhibitor of GSTs, to evaluate the relative role of GSTs in mediating cisplatin resistance in two human small-cell lung cancer cell lines, NCI H-69 and H-2496. The H-69 cell line, which contained relatively higher GST activity than the H-2496 cell line (317 ± 7 vs 9 ± 1 mU mg-1 protein respectively), also displayed a greater degree of cisplatin resistance (IC50 values of 25.0 ± 3.9 vs 4.5 ± 1.0 microM respectively). Western blot and Northern blot analyses of purified GSTs revealed the expression of only the pi-class GST in both cell lines. Sulphasalazine inhibited the purified GSTs (IC50 of 10 microM for H-69 and 12 microM for H-2496) from both lines in a competitive manner with similar Ki values (6.5 and 7.9 microM for the H-69 and H-2496 cell lines respectively). Cytotoxicity studies revealed that sulphasalazine increased the cytotoxicity of cisplatin towards both cell lines. Isobologram analysis showed that sulphasalazine synergistically enhanced the cytotoxicity of cisplatin towards both cell lines, the magnitude of synergy being remarkably higher in H-69 cells than in H-2496 cells. Our studies indicate that clinically achievable concentrations of sulphasalazine may be useful in modulating cisplatin resistance in malignancies with increased GST-pi content.

UR - http://www.scopus.com/inward/record.url?scp=0027990979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027990979&partnerID=8YFLogxK

U2 - 10.1038/bjc.1994.278

DO - 10.1038/bjc.1994.278

M3 - Article

VL - 70

SP - 190

EP - 194

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 2

ER -